Q32 Bio Inc.
QTTB
$15.15
-$0.22-1.43%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 53.74M | 53.74M | 53.74M | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 53.74M | 53.74M | 53.74M | -- | -- |
| Cost of Revenue | 14.35M | 15.25M | 19.16M | 26.39M | 37.18M |
| Gross Profit | 39.39M | 38.49M | 34.58M | -26.39M | -37.18M |
| SG&A Expenses | 17.93M | 17.08M | 17.68M | 17.12M | 17.56M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 32.28M | 32.33M | 36.83M | 43.50M | 54.74M |
| Operating Income | 21.46M | 21.41M | 16.90M | -43.50M | -54.74M |
| Income Before Tax | 33.79M | 33.24M | 29.82M | -42.08M | -52.28M |
| Income Tax Expenses | -- | -- | -- | 21.00K | 21.00K |
| Earnings from Continuing Operations | 33.79 | 33.24 | 29.82 | -42.10 | -52.30 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 33.79M | 33.24M | 29.82M | -42.10M | -52.30M |
| EBIT | 21.46M | 21.41M | 16.90M | -43.50M | -54.74M |
| EBITDA | 21.82M | 21.77M | 17.29M | -43.08M | -54.29M |
| EPS Basic | 3.01 | 2.67 | 2.31 | -3.45 | -4.30 |
| Normalized Basic EPS | 1.31 | 1.09 | 0.86 | -2.94 | -3.47 |
| EPS Diluted | 3.01 | 2.67 | 2.30 | -3.45 | -4.31 |
| Normalized Diluted EPS | 1.30 | 1.09 | 0.86 | -2.94 | -3.47 |
| Average Basic Shares Outstanding | 59.24M | 51.10M | 49.20M | 48.82M | 48.65M |
| Average Diluted Shares Outstanding | 59.27M | 51.13M | 49.23M | 48.82M | 48.65M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |